Barinthus Biotherapeutics BRNS
BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Barinthus Biotherapeutics (BRNS) posted Return on Capital Employed [ROCE] of -57.84% for Q2 2026, up 4.48 percentage points from -62.33% a year earlier and up 9.54 percentage points from the prior quarter.

Analysis

Barinthus Biotherapeutics (BRNS) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Barinthus Biotherapeutics' Return on Capital Employed [ROCE] came in at -59.18%, down 19.60 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three consecutive years, with a four-year change of -29.91 percentage points (FY2021 to FY2025).
  • In prior years, Barinthus Biotherapeutics' Return on Capital Employed [ROCE] was -39.57% in FY2024 (-3.05 pp), -36.52% in FY2023 (-34.99 pp), -1.54% in FY2022 (+27.73 pp) and -29.26% in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -14.35 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2022, with a gain of 16.84 percentage points; the weakest was Q3 2023, with a drop of 42.23 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -67.38% (Q1 2026), -75.33% (Q4 2025) and -75.87% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Barinthus Biotherapeutics 30.23 Mn 30.29 Mn - -57.84%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.84%
Mar 31, 2026 -67.38%
Dec 31, 2025 -75.33%
Sep 30, 2025 -75.87%
Jun 30, 2025 -62.33%
Mar 31, 2025 -51.48%
Dec 31, 2024 -42.79%
Sep 30, 2024 -37.40%
Jun 30, 2024 -40.16%
Mar 31, 2024 -40.87%
Dec 31, 2023 -40.03%
Sep 30, 2023 -40.56%
Jun 30, 2023 -27.16%
Mar 31, 2023 -10.28%
Dec 31, 2022 -1.52%
Sep 30, 2022 1.67%
Jun 30, 2022 -3.04%
Mar 31, 2022 -14.38%
Dec 31, 2021 -17.56%
Sep 30, 2021 -15.16%
API Access

Barinthus Biotherapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BRNS&period=max&api_key=YOUR_API_KEY